Experiments conducted by Zhang et al. indeed confirm that the CD90− subpopulation mainly boost glioma cell proliferation, migration, and adhesion, whereas the CD90+ subpopulation primarily facilitates neoangiogenesis via pericyte differentiation and interaction with endothelial cells [168]. Here, THY1 is linked to central nervous system cancer.